HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osamu Yokoyama Selected Research

Monoclonal Antibodies

11/2015A potential role for 6-sulfo sialyl Lewis X in metastasis of bladder urothelial carcinoma.
10/2012Monoclonal antibody RM2 as a potential ligand for a new immunotracer for prostate cancer imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Osamu Yokoyama Research Topics

Disease

30Overactive Urinary Bladder (Overactive Bladder)
11/2022 - 04/2004
17Cerebral Infarction
08/2017 - 01/2002
14Neoplasms (Cancer)
04/2021 - 05/2004
13Nocturia
11/2021 - 04/2010
13Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2019 - 09/2006
12Lower Urinary Tract Symptoms
01/2018 - 09/2008
11Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2011
10Urinary Incontinence
11/2021 - 04/2014
6Urinary Retention
09/2021 - 11/2007
6Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 09/2011
6Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
08/2017 - 11/2002
5Spinal Cord Injuries (Spinal Cord Injury)
09/2021 - 02/2004
5Carcinoma (Carcinomatosis)
01/2021 - 01/2011
5Inflammation (Inflammations)
10/2020 - 02/2010
5Polyuria
05/2015 - 04/2011
4Neoplasm Metastasis (Metastasis)
01/2021 - 01/2013
4Stress Urinary Incontinence
01/2021 - 11/2013
3Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
01/2019 - 11/2007
2Hematuria
09/2021 - 05/2008
2Hypertension (High Blood Pressure)
01/2018 - 11/2015
2Constipation
01/2018 - 04/2014
2Ataxia (Dyssynergia)
11/2016 - 02/2004
1Underactive Urinary Bladder
11/2022
1Hypoxia (Hypoxemia)
06/2022
1Ischemia
06/2022
1Hypoalbuminemia
12/2021
1Diarrhea
12/2021
1Pyelonephritis
12/2021
1Multiple Sclerosis
09/2021
1Hemorrhage
09/2021
1Epididymitis
09/2021

Drug/Important Bio-Agent (IBA)

9Muscarinic AntagonistsIBA
01/2019 - 11/2005
8Cholinergic Antagonists (Anticholinergics)IBA
01/2021 - 10/2009
7Tadalafil (Cialis)FDA Link
01/2020 - 02/2013
5Hormones (Hormone)IBA
01/2021 - 05/2004
5resiniferatoxinIBA
01/2019 - 11/2005
5propiverineIBA
01/2018 - 04/2011
5Solifenacin SuccinateFDA Link
10/2015 - 07/2011
5imidafenacinIBA
05/2015 - 06/2011
5Tamsulosin (Flomax)FDA LinkGeneric
01/2014 - 04/2011
4Docetaxel (Taxotere)FDA Link
10/2019 - 01/2011
4naftopidilIBA
01/2019 - 01/2006
3Prostate-Specific Antigen (Semenogelase)IBA
11/2021 - 05/2013
3Type A Botulinum Toxins (Botox)FDA Link
11/2021 - 03/2020
3Botulinum Toxins (Botulinum Toxin)IBA
09/2021 - 03/2020
3Polysaccharides (Glycans)IBA
01/2021 - 11/2015
3LigandsIBA
01/2021 - 10/2012
3Sialyl Lewis X AntigenIBA
01/2021 - 11/2015
3N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA
01/2021 - 01/2019
3Phosphodiesterase 5 InhibitorsIBA
01/2020 - 10/2015
3mirabegronIBA
01/2019 - 06/2014
3salicylhydroxamic acid (SHAM)IBA
01/2019 - 12/2007
3Therapeutic UsesIBA
01/2018 - 01/2011
3Tolterodine Tartrate (Detrol)FDA Link
04/2014 - 11/2005
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2021 - 05/2013
2E-SelectinIBA
01/2021 - 11/2015
2CA-19-9 Antigen (CA 19-9 Antigen)IBA
01/2021 - 11/2015
2CarbohydratesIBA
01/2021 - 10/2017
2C-Reactive ProteinIBA
10/2020 - 01/2019
2Gonadal Steroid Hormones (Sex Hormones)IBA
01/2020 - 09/2008
2DNA (Deoxyribonucleic Acid)IBA
11/2019 - 06/2004
2Dinoprostone (PGE2)FDA Link
01/2018 - 06/2011
2fesoterodineFDA Link
01/2018 - 04/2014
2Proteins (Proteins, Gene)FDA Link
10/2017 - 02/2010
2Nerve Growth Factor (NGF)IBA
08/2017 - 11/2010
2Halothane (Fluothane)FDA Link
08/2017 - 05/2003
2Monoclonal AntibodiesIBA
11/2015 - 10/2012
2oxybutynin (Tavor)FDA LinkGeneric
07/2015 - 04/2014
2silodosinFDA Link
01/2014 - 09/2006
2Adrenergic Receptors (Adrenergic Receptor)IBA
11/2013 - 10/2008
2Prednisolone (Predate)FDA LinkGeneric
09/2013 - 05/2013
2Carboplatin (JM8)FDA LinkGeneric
05/2013 - 03/2011
2Paclitaxel (Taxol)FDA LinkGeneric
05/2013 - 03/2011
2Cisplatin (Platino)FDA LinkGeneric
01/2013 - 03/2011
2Sunitinib (Sutent)FDA Link
11/2011 - 09/2011
2Adenosine Triphosphate (ATP)IBA
06/2011 - 11/2002
2Cyclooxygenase InhibitorsIBA
01/2011 - 02/2010
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2010 - 07/2005
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2010 - 01/2002
2N-Methylaspartate (NMDA)IBA
01/2010 - 01/2002
2Glutamate Receptors (Glutamate Receptor)IBA
01/2010 - 04/2004
2Messenger RNA (mRNA)IBA
05/2003 - 01/2002
1tac-302IBA
11/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2022
1CytokinesIBA
06/2022
18-Hydroxy-2'-DeoxyguanosineIBA
06/2022
1Amyloid (Amyloid Fibrils)IBA
12/2021
1AA amyloidosisIBA
12/2021

Therapy/Procedure

18Therapeutics
03/2021 - 05/2004
6Drug Therapy (Chemotherapy)
10/2019 - 03/2011
5Castration
01/2021 - 05/2013
2Conservative Treatment
10/2017 - 01/2010
2Anesthesia
08/2017 - 05/2003
2Lasers (Laser)
05/2017 - 06/2013
2Brachytherapy
01/2016 - 01/2014
2Orchiectomy (Orchidectomy)
04/2015 - 05/2003
2Nephrectomy
11/2013 - 11/2011
2Combination Drug Therapy (Combination Chemotherapy)
09/2013 - 03/2011
2Prostatectomy (Retropubic Prostatectomy)
05/2013 - 05/2004
1Injections
09/2021